- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Mergers and Acquisitions
Is Sanofi’s Bioverative Inc Buyout Just the Start?
Bioverativ and Juno Therapeutics both drew buyout bids as drug companies seek to use CAR-T therapy against cancer profitably.
Bayer AG (ADR) (BAYRY) Makes the Monsanto Deal Work
Bayer stock doesn't get much love thanks to its over-the-counter (OTC) listing, but BAYRY is a buy if this buyout goes through.
Tie-Up Tuesday: M&A Activity Heats Up Once Again
A frenzied year for M&A continued apace as companies in diverse sectors with major U.S. listings announced $12 billion in deal activity on Tuesday.
The Big Winners in Teva’s Acquisition of Allergan Generics
Teva and Allergan benefit the most from the $40 billion deal, but prospects remain bright for Mylan, Perrigo and, indeed, the wider sector.
Cigna Should Demand a Bigger Bid from Anthem (CI, ANTM)
Cigna wants an even bigger bid from Anthem, and why not? The industry is awash in M&A, and that makes CI stock a hot target for others.
Expect More M&A After T-Mobile Closes the DISH Deal
T-Mobile's deal to buy DISH Network will likely accelerate mergers and acquisitions in the cable and telecommunications sectors.
Pharma M&A a Sure Bet as Endo Buys Par Pharma for $8B
Endo Pharmaceuticals' deal for Par Pharma is just the latest tie-up in a red hot year for mergers and acquisitions.
Why Comcast and Time Warner Cable Dodged a Bullet (CMCSA, TWC)
The end of Comcast's deal to buy Time Warner Cable is good news for CMCSA and TWC shareholders.